International Menopause Society

Last updated
International Menopause Society (IMS)
Int Menopause Society Logo.jpg
  • 13 Leechwell Street, Totnes, Devon TQ9 5SX, UK
Area served
Key people
Prof Susan Davis, current President, Rebecca Cheshire, current Chief Executive Officer

The International Menopause Society (IMS) is a UK based charity. The Association was created in 1978 in Jerusalem during the second Menopause Congress and currently has members in 62 countries. In addition to organizing congresses, symposia, and workshops, the IMS owns its own journal: Climacteric, the Journal of Adult Women's Health and Medicine, published by Taylor & Francis.


Resources and publications

The Society's official journal, Climacteric , the Journal of Adult Women's Health and Medicine, was founded in 1998 and is listed in Index Medicus/MEDLINE. [1] The Editor-in-Chief is Rodney Baber Australia. It publishes international, original, peer-reviewed research on all aspects of aging in women, especially during the menopause and climacteric. The content of the journal covers the whole range of subject areas relevant to climacteric studies and adult women’s health and medicine, including underlying endocrinological changes, treatment of the symptoms of the menopause and other age-related changes, hormone replacement therapies, alternative therapies, effective life-style modifications, non-hormonal midlife changes, and the counselling and education of perimenopausal and postmenopausal patients. [2] [3]

World Congress on the Menopause

The IMS hold a biennial World Congress in the different regions of the world, the 17th being held in Melbourne, Australia in 2020.[ citation needed ]

Related Research Articles

Menopause when menstrual periods stop permanently

Menopause, also known as the climacteric, is the time in most women's lives when menstrual periods stop permanently, and they are no longer able to bear children. Menopause typically occurs between 49 and 52 years of age. Medical professionals often define menopause as having occurred when a woman has not had any vaginal bleeding for a year. It may also be defined by a decrease in hormone production by the ovaries. In those who have had surgery to remove their uterus but still have ovaries, menopause may be considered to have occurred at the time of the surgery or when their hormone levels fell. Following the removal of the uterus, symptoms typically occur earlier, at an average of 45 years of age.

Estradiol a steroid, an estrogen, and the primary female sex hormone

Estradiol (E2), also spelled oestradiol, is an estrogen steroid hormone and the major female sex hormone. It is involved in the regulation of the estrous and menstrual female reproductive cycles. Estradiol is responsible for the development of female secondary sexual characteristics such as the breasts, widening of the hips, and a female-associated pattern of fat distribution and is important in the development and maintenance of female reproductive tissues such as the mammary glands, uterus, and vagina during puberty, adulthood, and pregnancy. It also has important effects in many other tissues including bone, fat, skin, liver, and the brain. Though estradiol levels in males are much lower compared to those in females, estradiol has important roles in males as well. Apart from humans and other mammals, estradiol is also found in most vertebrates and crustaceans, insects, fish, and other animal species.

Estrone chemical compound

Estrone (E1), also spelled oestrone, is a steroid, a weak estrogen, and a minor female sex hormone. It is one of three major endogenous estrogens, the others being estradiol and estriol. Estrone, as well as the other estrogens, are synthesized from cholesterol and secreted mainly from the gonads, though they can also be formed from adrenal androgens in adipose tissue. Relative to estradiol, both estrone and estriol have far weaker activity as estrogens. Estrone can be converted into estradiol, and serves mainly as a precursor or metabolic intermediate of estradiol.

Hot flashes are a form of flushing due to reduced levels of estradiol. Hot flashes are a symptom which may have several other causes, but which is often caused by the changing hormone levels that are characteristic of menopause. They are typically experienced as a feeling of intense heat with sweating and rapid heartbeat, and may typically last from 2 to 30 minutes for each occurrence.

Bioidentical hormone replacement therapy (BHRT), also known as bioidentical hormone therapy or natural hormone therapy, is the use of hormones that are identical on a molecular level with endogenous hormones in hormone replacement therapy. It may also be combined with blood and saliva testing of hormone levels, and the use of pharmacy compounding to obtain hormones in an effort to reach a targeted level of hormones in the body. A number of claims by some proponents of bioidentical hormone replacement therapy have not been definitively established through scientific testing. Specific hormones used in BHT include estrone, estradiol, progesterone, testosterone, dehydroepiandrosterone (DHEA), and estriol.

Late-onset hypogonadism or Testosterone Deficiency Syndrome (TDS) is a condition in older men characterized by measurably low testosterone levels and clinical symptoms mostly of a sexual nature, including decreased desire for sex, fewer spontaneous erections, and erectile dysfunction. It is the result of a gradual drop in testosterone; a steady decline in testosterone levels of about 1% per year can happen and is well documented in both men and women.

Estradiol acetate chemical compound

Estradiol acetate (EA), sold under the brand names Femtrace, Femring, and Menoring, is an estrogen medication which is used in hormone therapy for the treatment of menopausal symptoms in women. It is taken by mouth once daily or given as a vaginal ring once every three months.

Prasterone medical usage of the prasterone compound

Prasterone, also known as dehydroepiandrosterone (DHEA) and sold under the brand names Intrarosa, Diandrone, and Gynodian Depot among others, is a medication as well as over-the-counter dietary supplement which is used to correct DHEA deficiency due to adrenal insufficiency or old age, as a component of menopausal hormone therapy, to treat painful sexual intercourse due to vaginal atrophy, and to prepare the cervix for childbirth, among other uses. It is taken by mouth, by application to the skin, in through the vagina, or by injection into muscle.

Tibolone chemical compound

Tibolone, sold under the brand names Livial, Tinox and Tibofem among others, is a medication which is used in menopausal hormone therapy and in the treatment of postmenopausal osteoporosis and endometriosis. The medication is available alone and is not formulated or used in combination with other medications. It is taken by mouth.

Dydrogesterone chemical compound

Dydrogesterone, sold under the brand name Duphaston and Femoston, is a progestin medication which is used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal hormone therapy. It is taken by mouth.

The Million Women Study is a study of women’s health analysing data from more than one million women aged 50 and over, led by Dame Valerie Beral and a team of researchers at the Cancer Epidemiology Unit, University of Oxford. It is a collaborative project between Cancer Research UK and the National Health Service (NHS), with additional funding from the Medical Research Council (UK).

Hormone replacement therapy (HRT), also known as menopausal hormone therapy (MHT) or postmenopausal hormone therapy, is a form of hormone therapy used to treat symptoms associated with female menopause. These symptoms can include hot flashes, vaginal atrophy, accelerated skin aging, vaginal dryness, decreased muscle mass, sexual dysfunction, and bone loss. They are in large part related to the diminished levels of sex hormones that occur during menopause.

<i>Climacteric</i> (journal) peer-reviewed scientific journal

Climacteric is a bimonthly peer-reviewed medical journal that covers all aspects of aging in women, especially during the menopause. As the official journal of the International Menopause Society, Climacteric also publishes position statements and workshop proceedings from the society.

The anti-aging movement is a social movement devoted to eliminating or reversing aging, or reducing the effects of it. A substantial portion of the attention of the movement is on the possibilities for life extension, but there is also interest in techniques such as cosmetic surgery which ameliorate the effects of aging rather than delay or defeat it.

Wulf H. Utian

Wulf H. Utian is a physician, reproductive endocrinologist, clinical researcher, and academic women's health department administrator. He is best known for first recognizing menopause as a potential health-related issue. He is the co-founder of the International Menopause Society and founder of the North American Menopause Society. Previously he has worked as a medical department administrator at the Mount Sinai Medical Center, the University Hospitals of Cleveland, and academic chairman of the department of Reproductive Biology at Case Western Reserve University School of Medicine. He is currently the Arthur H. Bill Professor Emeritus of Reproductive Biology at the Case Western Reserve University School of Medicine, a consultant in women's health, and Scientific Director of Rapid Medical Research Inc.

Florence Comite American endocrinologist

Dr. Florence Comite is an endocrinologist who has helped develop new therapies for osteoporosis, endometriosis, fibroid disease, and infertility. She is known for patent approval for developing a new method of determining fertility in women In 1990, Dr. Comite was awarded a second patent for the use of clomifene to increase bone mass in premenopausal women.

Lawley Pharmaceuticals

Lawley Pharmaceuticals is a privately owned Australian pharmaceutical company established by pharmacist Michael Buckley in 1995.

Prasterone enanthate chemical compound

Prasterone enanthate, also known as dehydroepiandrosterone enanthate (DHEA-E) and sold in combination with estradiol valerate under the brand name Gynodian Depot among others, is a weak androgen, estrogen, and neurosteroid medication which is used as a component of menopausal hormone therapy to treat menopausal symptoms in women. It is available only as an injectable preparation in combination with estradiol valerate. The medication is given by injection into muscle typically once ever 4 weeks.

Alastair MacLennan (obstetrician) Scottish-Australian professor of obstetrics and gynaecology, medical researcher, and community health advocate (born 1945).

Alastair Harvey MacLennan, AO, MB ChB, MD, FRCOG, FRANZCOG is a Scottish-Australian doctor, professor of obstetrics and gynaecology, medical researcher, and a community health advocate. He studied and practised medicine in Glasgow, Chicago, and Oxford before moving to Australia in 1977 to take up a position at the University of Adelaide, where he went on to become the Professor and Head of the Discipline of Obstetrics and Gynaecology in 2006. He retired from his full-time academic position in 2013, and he is now Emeritus Professor of Medicine. He leads research projects at the Robinson Research Institute, and he is Head of the university's Cerebral Palsy Research Group.

Estrogen (medication) Female Hormones

An estrogen (E) is a type of medication which is used most commonly in hormonal birth control and menopausal hormone therapy. They can also be used in the treatment of hormone-sensitive cancers like breast cancer and prostate cancer and for various other indications. Estrogens are used alone or in combination with progestogens. They are available in a wide variety of formulations and for use by many different routes of administration. Examples of estrogens include bioidentical estradiol, natural conjugated estrogens, synthetic steroidal estrogens like ethinylestradiol, and synthetic nonsteroidal estrogens like diethylstilbestrol. Estrogens are one of three types of sex hormone agonists, the others being androgens/anabolic steroids like testosterone and progestogens like progesterone.


  1. "Understanding Weight Gain at Menopause". Climacteric. Retrieved 2012-10-27.
  2. "The British Menopause Society: For UK health professionals". Archived from the original on 2012-11-09. Retrieved 2012-10-27.
  3. Kelland, Kate. "DHEA hormone may help women through menopause: study". Reuters. Retrieved 2012-10-27.